...
pfe-img

Pfizer Inc, Common Stock

PFE

NYQ

$26.36

+$0.59

(2.29%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$146.04B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
34.36
Volume info-icon
This is the total number of shares traded during the most recent trading day.
83.04M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
6.67%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.61
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$24.11 L
$31.06 H
$26.36

About Pfizer Inc, Common Stock

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as has strategic clinical collaboration with Acepodia Inc. for the development of antibody-cell conjugation-based cell therapies in autoimmune diseases. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FramePFESectorS&P500
1-Week Return3.05%-2.12%-3%
1-Month Return5.69%-3.42%-0.73%
3-Month Return-10.4%-11.13%2.87%
6-Month Return-4.97%-5.74%7.17%
1-Year Return-4.6%3.97%25.31%
3-Year Return-56.8%1.05%28.38%
5-Year Return-29.07%34.37%81.89%
10-Year Return-13.29%97.88%183.27%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue51.75B41.91B81.29B100.33B58.50B[{"date":"2019-12-31","value":51.58,"profit":true},{"date":"2020-12-31","value":41.77,"profit":true},{"date":"2021-12-31","value":81.02,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":58.3,"profit":true}]
Cost of Revenue10.22B8.69B30.82B34.34B29.69B[{"date":"2019-12-31","value":29.75,"profit":true},{"date":"2020-12-31","value":25.31,"profit":true},{"date":"2021-12-31","value":89.74,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":86.44,"profit":true}]
Gross Profit41.53B33.22B50.47B65.99B28.81B[{"date":"2019-12-31","value":62.94,"profit":true},{"date":"2020-12-31","value":50.34,"profit":true},{"date":"2021-12-31","value":76.48,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":43.66,"profit":true}]
Gross Margin80.25%79.26%62.08%65.77%49.25%[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":98.76,"profit":true},{"date":"2021-12-31","value":77.36,"profit":true},{"date":"2022-12-31","value":81.95,"profit":true},{"date":"2023-12-31","value":61.37,"profit":true}]
Operating Expenses27.61B24.46B30.23B28.71B25.45B[{"date":"2019-12-31","value":91.33,"profit":true},{"date":"2020-12-31","value":80.89,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":94.98,"profit":true},{"date":"2023-12-31","value":84.18,"profit":true}]
Operating Income15.14B10.63B24.83B40.03B3.36B[{"date":"2019-12-31","value":37.81,"profit":true},{"date":"2020-12-31","value":26.56,"profit":true},{"date":"2021-12-31","value":62.04,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":8.39,"profit":true}]
Total Non-Operating Income/Expense1.20B(4.97B)(3.92B)(3.53B)(2.89B)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-415.2,"profit":false},{"date":"2021-12-31","value":-327.82,"profit":false},{"date":"2022-12-31","value":-294.9,"profit":false},{"date":"2023-12-31","value":-241.1,"profit":false}]
Pre-Tax Income17.68B7.50B24.31B34.73B1.06B[{"date":"2019-12-31","value":50.91,"profit":true},{"date":"2020-12-31","value":21.59,"profit":true},{"date":"2021-12-31","value":70,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":3.05,"profit":true}]
Income Taxes1.38B477.00M1.85B3.33B(1.11B)[{"date":"2019-12-31","value":41.59,"profit":true},{"date":"2020-12-31","value":14.33,"profit":true},{"date":"2021-12-31","value":55.65,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-33.47,"profit":false}]
Income After Taxes16.30B7.02B22.46B31.40B2.17B[{"date":"2019-12-31","value":51.9,"profit":true},{"date":"2020-12-31","value":22.36,"profit":true},{"date":"2021-12-31","value":71.52,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":6.92,"profit":true}]
Income From Continuous Operations16.30B7.02B22.46B31.40B2.17B[{"date":"2019-12-31","value":51.9,"profit":true},{"date":"2020-12-31","value":22.36,"profit":true},{"date":"2021-12-31","value":71.52,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":6.92,"profit":true}]
Income From Discontinued Operations4.00M2.63B(434.00M)6.00M-[{"date":"2019-12-31","value":0.15,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":-16.5,"profit":false},{"date":"2022-12-31","value":0.23,"profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income16.27B7.02B21.98B31.37B2.12B[{"date":"2019-12-31","value":51.87,"profit":true},{"date":"2020-12-31","value":22.38,"profit":true},{"date":"2021-12-31","value":70.06,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":6.75,"profit":true}]
EPS (Diluted)2.952.724.426.631.83[{"date":"2019-12-31","value":44.49,"profit":true},{"date":"2020-12-31","value":41.03,"profit":true},{"date":"2021-12-31","value":66.67,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":27.6,"profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

PFE
Cash Ratio 0.23
Current Ratio 1.00
Quick Ratio 0.73

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PFE
ROA (LTM) 3.31%
ROE (LTM) 4.54%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PFE
Debt Ratio Lower is generally better. Negative is bad. 0.58
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.42

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PFE
Trailing PE 34.36
Forward PE 8.69
P/S (TTM) 2.46
P/B 1.59
Price/FCF 24
EV/R 3.43
EV/Ebitda 14.70
PEG 0.18

FAQs

What is Pfizer Inc share price today?

Pfizer Inc (PFE) share price today is $26.36

Can Indians buy Pfizer Inc shares?

Yes, Indians can buy shares of Pfizer Inc (PFE) on Vested. To buy Pfizer Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PFE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Pfizer Inc be purchased?

Yes, you can purchase fractional shares of Pfizer Inc (PFE) via the Vested app. You can start investing in Pfizer Inc (PFE) with a minimum investment of $1.

How to invest in Pfizer Inc shares from India?

You can invest in shares of Pfizer Inc (PFE) via Vested in three simple steps:

  • Click on Sign Up or Invest in PFE stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Pfizer Inc shares
What is Pfizer Inc 52-week high and low stock price?

The 52-week high price of Pfizer Inc (PFE) is $31.06. The 52-week low price of Pfizer Inc (PFE) is $24.11.

What is Pfizer Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Pfizer Inc (PFE) is 34.36

What is Pfizer Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Pfizer Inc (PFE) is 1.59

What is Pfizer Inc dividend yield?

The dividend yield of Pfizer Inc (PFE) is 6.67%

What is the Market Cap of Pfizer Inc?

The market capitalization of Pfizer Inc (PFE) is $146.04B

What is Pfizer Inc’s stock symbol?

The stock symbol (or ticker) of Pfizer Inc is PFE

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top